TCL Archive Amgen Agrees to Settle Aranesp Marketing Lawsuit, Reserves $780 Million For Settlement October 28, 2011
TCL Archive ODAC Finds Increase In Progression-Free Survival Unconvincing To Approve sNDA For Gemzar In Advanced Ovarian Cancer. March 24, 2006